Selected Publications

Cadnapaphornchai MA, Dell KM, Gimpel C, Guay-Woodford LM, Gulati A, Hartung EA, Liebau MC, Mallett AJ, Marlais M, Mekahli D, Piccirilli A, Seeman T, Tindal K, Winyard PJD.: Polycystic Kidney Disease in Children: The Current Status and the Next Horizon. Am J Kidney Dis. 86(3): 383-392, Sep 2025 Notes: 2025 Mar 28:S0272-6386(25)00772-3. doi: 10.1053/j.ajkd.2025.01.022.

Tu T, Ochoa A, Sood A, Drabik A, Chryst-Stangl M, Lane B, Wu G, Donovan F, Harper U, Chandrasekharappa S, Esezobor C, Solarin A, Hooper D, Sethna C, Amaral S, Kallash M, Rheault M, Verghese P, Dharnidharka V, Salmon E, Weng P, Srivastava T, Seifert ME, Pruette C, Selewski D, Gibson K, Hunley T, Abeyagunawardena A, Thalgahagoda S, Bagga A, Sinha A, Webb N, Greenbaum L, Gharavi A, Kiryluk K, Kretzler M, Guay-Woodford L, Sanna-Cherchi S, Bierzynska A, Koziell A, Welsh G, Saleem M, Rotimi C, Chambers E, Chan C; CureGN Consortium; PNRC Glomerular disease group; CIBMTR/NMDP Consortium; Jackson A, Adeyemo A, Gbadegesin R.: Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome. medRxiv [Preprint]. Aug 7 2025 Notes: 2025.08.01.25332825.doi:10.1101/2025.08.01.25332825.

Cummins TD, Mariani LH, Wilkey DW, Jortani SA, Helmuth M, Rane MJ, Merchant ML, Kamigaki Y, Theesfeld C, McCown PJ, Ju W, Dougherty JA, McRitchieS, Pathmasiri W, Kretzler M, Sumner SJ, Smoyer WE, Klein JB; Cure Glomerulonephropathy (CureGN) Consortium.: Defining subgroups of pediatric nephrotic patients with urine proteomics. Sci Rep. 15(1): 25064, Jul 2025.

Salcedo-Giraldo J, Wink KR, Dadzie N, Freiman A, Pyle T, Gordish-Dressman H, Moxey-Mims M, Dahl NK, Guay-Woodford LM, Gulati A.: Inherited and Polycystic Kidney Disease (IPKD) Program at Children's National Hospital, Washington, DC. Structured Application of Genetic Testing in a Pediatric Kidney Clinic. J Am Soc Nephrol. Jul 29 2025 Notes: doi:10.1681/ASN.0000000816.Epub ahead of print.

Gimpel C, Fieuws S, Hofstetter J, Pitcher D, Vanmeerbeek L, Haeberle S, Dachy A, Massella L, Seeman T, Ranchin B, Allard L, Bacchetta J, Bayrakci US, Becherucci F, Perez-Beltran V, Besouw M, Bialkevich H, Boyer O, Canpolat N, Chauveau D, Çiçek N, Conlon PJ, Devuyst O, Dossier C, Fila M, Flögelová H, Godron-Dubrasquet A, Gokce I, Nguyen-Tang EG, González-Rodríguez JD, Guffens A, Grandaliano G, Heidet L, Jankauskiene A, Levart TK, Knebelmann B, König JC, La Scola C, Leone VF, Leroy V, Litwin M, Lucchetti L, Lungu AC, Marzuillo P, Mastrangelo A, Miklaszewska M, Montini G, Nobili F, Obrycki L, Papizh S, Paripović A, Paripović D, Peruzzi L, Raes A, Saygili S, Spasojević B, Simon T, Szczepańska M, Trepiccione F, Varda NM, Westland R, Yüksel S, Zaluska-Lesniewska I, Tenebaum J, Mustafa R, Mallett AJ, Guay-Woodford LM, Gale DP, Böckenhauer D, Liebau MC, Schaefer F, Mekahli D; RaDaR ADPKD Rare Disease Group; ERKReg Collaborators; ADPedKD Collaborators.: Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation ofchildhood autosomal dominant polycystic kidney disease in high- and middle-income countries. Kidney Int. 108(1): 105-118, Jul 2025 Notes: Epub 2025 Mar 21.

Watson D, Mentch F, Billings J, Ostberg K, March ME, Kalish JM, Li D, Cannon I, Guay-Woodford LM, Hartung E, Strong A.: Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises. Am J Med Genet A. 197(6): e64011, Jun 2025 Notes: Epub 2025 Jan 30.

Glenn DA, Carver AW, Helmuth ME, Smith AR, Lafayette RA, Ravipati P, Oliverio AL, Rizk DV, Novak J, Lugani F, Bartosh SM, Mucha K, Kiryluk K, Saha MK, Nast CC, Hou J, Biederman LE, Messias N, Rosenberg AZ, Reich HN, Canetta PA, Nachman PH, Nester C, Bou-Matar R, Wadhwani S, Mariani LH, Khalid M; CureGN IgA Working Group.: Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis. Clin J Am Soc Nephrol. 20(7): 978-992, Apr 2025.

Laurin LP, Helmuth M, Almaani S, Ayoub I, Chen DP, Villegas LA, Nast CC, Robinson BM, Derebail VK, Waldman M, Bomback AS; CureGN Consortium.: Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN). Kidney Int Rep. 10(6): 1917-1928, Mar 2025.

Zanoni F, Marasa M, Carlassara L, Verbitsky M, Khan A, Wang C, Bundy JD, Canetta PA, Bomback AS, Parsa A, Feldman HI, Gharavi AG, Kiryluk K; CRIC Study Investigators and the CureGN Study.: Family History in the Context of CKD. J Am Soc Nephrol. 36(8): 1561-1571, Mar 2025.

Ames EG, Anand PM, Bekheirnia MR, Doshi MD, El Ters M, Freese ME, Gbadegesin RA, Guay-Woodford LM, Java A, Ranch D, Rodig NM, Wang X, Thomas CP.: Evaluation for genetic disease in kidney transplant candidates: A practice resource. Am J Transplant. 25(2): 237-249, Feb 2025 Notes: Epub 2024 Oct 31.